This message contains images. If you don't see images, click here to view.
Advertise in this news brief.

  Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit         June 10, 2016



Collaborating: It's about People Share on FacebookTwitterShare on LinkedinE-mail article
Your new company believes in integrated teams when it comes to problem solving. You soon find yourself on a large, multidisciplinary collaboration team faced with a challenge that has no clear path to a solution. How do you begin to work with your teammates?

Find advice about nurturing collaborative relationships along with some online resources in the June Career Success feature, now online.


Job Title Company Location
Principal Investigator/Associate Director, Formulation Development Ironwood Pharmaceuticals Cambridge, MA
Associate Group Leader - PI - Senior Scientist (CRO - Immunochemistry - Bioanalytical Labs Team) PPDI - Pharmaceutical Product Development Inc. Richmond, VA
Senior Scientist, Clinical Pharmacology Genentech South San Francisco, CA
Head, Drug Product Process Development Moderna Therapeutics Cambridge, MA

For a complete list of job postings, click here.

Have a job to post? Click here.


Biopharma Supports Nearly 4.5 Million US Jobs, Says Report Share on FacebookTwitterShare on LinkedinE-mail article
The biopharma industry supported nearly 854,000 direct jobs and another 3.5 million jobs and more than $1.2 trillion in economic output in the United States in 2014, according to new research prepared for the Pharmaceutical Research and Manufacturers of America (PhRMA). The report, which analyzed state and national data across the large-scale biopharmaceutical sector supply chain, highlights how the discovery, development and delivery of innovative medicines translate into higher-wage jobs, increased tax revenue and greater economic output in our local communities.  READ MORE

US CDC Unveils Funds To Fight Zika Locally Share on FacebookTwitterShare on LinkedinE-mail article
Pharmaceutical Business Review
The U.S. health department has made available more than $85m in redirected funds to fight Zika infection in the country. U.S. states and territories can now apply to the Centers for Disease Control and Prevention (CDC) for funds to fight Zika locally. The CDC said $25m in preparedness and response funding for 2016 will go to 53 states, cities, and territories at risk for outbreaks.  READ MORE

Pharma, The FDA And Social Media Share on FacebookTwitterShare on LinkedinE-mail article
The pharmaceutical industry is beginning to embrace more communications and social channels. According to a recent study, since 2013, the average number of tweets by pharmaceutical companies has gone up by 530 percent. Top industry players have increased their Twitter followers by nearly 300 percent. Yet, although firms see the benefits, many are reluctant to wade into the social waters.  READ MORE

Insider Secrets to Landing a Pharmaceutical Sales Job Share on FacebookTwitterShare on LinkedinE-mail article
Pharma sales jobs are some of the most highly sought after jobs in healthcare. With the impressive average pharmaceutical sales salary and plenty of other perks, pharma jobs are still highly competitive. While the number of pharma sales jobs is significantly lower now than it was 10 years ago, the job is still important and while the responsibilities of the job may change, pharma companies will always need sales reps. For sales reps, this is encouraging news.  READ MORE

US FDA Issues Draft Rules On Comparability Protocols For Human Drugs and Biologics, Seeks Response Before July Share on FacebookTwitterShare on LinkedinE-mail article
U.S. FDA has issued a draft guidance on Comparability Protocols for Human Drugs and Biologics: Chemistry, Manufacturing, and Controls Information. The regulatory authority expects the industry to comment and revert with the same before July 1, 2016. This guidance provides recommendations to holders of applications for human drugs and biologics on implementing a chemistry, manufacturing, and controls (CMC) post approval change through the use of a comparability protocol (CP). It replaces the draft guidance that published in February 2003, titled Comparability Protocols: Chemistry, Manufacturing, and Controls Information.  READ MORE

How Big Pharma Uses Charity Programs to Cover for Drug Price Hikes Share on FacebookTwitterShare on LinkedinE-mail article
In August 2015, Turing Pharmaceuticals and its then-chief executive, Martin Shkreli, purchased a drug called Daraprim and immediately raised its price more than 5,000 percent. Within days, Turing contacted Patient Services Inc., or PSI, a charity that helps people meet the insurance copayments on costly drugs. Turing wanted PSI to create a fund for patients with toxoplasmosis, a parasitic infection that is most often treated with Daraprim.  READ MORE

The Career Advice You Need To Hear Share on FacebookTwitterShare on LinkedinE-mail article
The Huffington Post
She worked at Vogue for 14 years, InStyle for four and now she's one of the most important players at two of Conde Nast's biggest titles. No, we're not talking about an editor, we're talking about Connie Anne Phillips, the publisher and chief revenue officer at Glamour and Self. The Philly native is in charge of making money for the mags and has built an impressive career in sales, marketing and advertising. She's won a slew of awards, counts Anna Wintour as a mentor and tells it like it is.  READ MORE

Researchers Question Evidence Base For Alcohol Addiction Drug Share on FacebookTwitterShare on LinkedinE-mail article
The Pharmaceutical Journal
The licensing and recommendation of a drug used to reduce alcohol consumption in adults with alcohol dependence was based on insufficient evidence to prove its efficacy, according to researchers at the University of Stirling. Nalmefene, marketed as Selincro by Lundbeck, was approved for use by the European Medicines Agency (EMA) for use in Europe in 2013 and was subsequently recommended for NHS use by the National Institute for Health and Care Excellence (NICE) the following year.  READ MORE

Precision Medicine and the 21st Century Cures Act Share on FacebookTwitterShare on LinkedinE-mail article
Pharmacy Times
On July 10, 2015, a bill for the 21st Century Cures Act passed the House of Representatives by a very large margin: 344 to 77. The bill is currently before the Senate, and although nothing in life is certain but death and taxes, the bill is expected to pass later this year. The 21st Century Cures Act will have a huge impact on the pharmaceutical industry, nationally and globally. According to Statistica, the United States accounts for about 40 percent of the global pharmaceutical market, which was valued at around $365 million in 2014.  READ MORE

Gov't Taking Steps To Set Up Funds To Promote Pharma Sector Share on FacebookTwitterShare on LinkedinE-mail article
Business Standard
The government is taking a number of initiatives to help pharma firms upgrade technology and promote drug discovery and innovation in the country, Parliament was informed today. The Department of Pharmaceuticals is formulating a Pharmaceutical Technology Upgradation Assistance Scheme to support the pharma industry (medium enterprises only) "to upgrade their regulatory technology compliance from Schedule M of the Dugs and Cosmetics Act, 1940 to WHO-GMP norms by facilitating low interest loans", Minister of Chemicals and Fertilisers Ananth Kumar said in a reply to the Rajya Sabha.  READ MORE

AAPS Career Services
Colby Horton, Vice President of Publishing, MultiBriefs, 469.420.2601
Download media kit

Jessica Taylor, Medical Editor, MultiBriefs, 202.684.7169  
Contribute news

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the AAPS Pharmaceutical Career News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!

Recent issues

May 13, 2016
April 15, 2016
March 11, 2016
Feb. 12, 2016

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063